8-KThe WireRoutine
Reg FD Disclosure
Filed Jan 8, 2024 · 2y ago · Accession 0001714899-24-000031
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Denali Therapeutics Inc.
- Ticker
- DNLI
- CIK
- 1714899
- Form type
- 8-K
- Filing date
- Jan 8, 2024
- Report date
- Jan 8, 2024
- Document
- dnli-20240108.htm
- Size
- 1.1 MB